Zenalpha® (medetomidine and vatinoxan hydrochlorides) Injection for use
as a sedative and analgesic in dogs to facilitate clinical examinations,
clinical procedures and minor surgical procedures.

▪Short time to onset of sedation of 5-15 minutes
▪Short duration of sedation of ~45 minutes in most dogs
▪Multi-dose glass vials
▪Each ml contains 0.5 mg medetomidine hydrochloride and 10 mg vatinoxan
hydrochloride; and when indicated, can be reversed with atipamezole
hydrochloride
▪In a field study, dogs treated with Zenalpha® had a shorter time to
onset of sedation, shorter duration of sedation (recovered quicker) and
less cardiovascular and respiratory depression and adverse reactions
compared to dogs administered dexmedetomidine in the control group